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OBJECTIVE: To determine the central areas of activation by vagal nerve stimulation (VNS) in epilepsy. VNS 
is a promising neurosurgical method for treating patients with partial and secondary generalized epilepsy. 
The anti-epileptic mechanism of action from VNS is not well understood. 
METHODS: We performed H2 150 PET blood flow functional imaging on three patients with epilepsy in a 
vagal nerve stimulation study (E04 Protocol with Cyberonics). The three patients included two that had 
previous epilepsy surgery but continued to have frequent seizures. Seizure onset was frontal in two patients 
and bitemporal in the third patient. Twelve PET scans per subject were acquired every 10 minutes with a 
Siemens 953/A scanner. In 6 stimulus scans, VNS was activated for 60 seconds (2 rnA, 30 Hz) 
commensurate with isotope injection. In 6 control scans no VNS was administered. No clinical seizures 
were present during any scan. Three way ANOVA with linear contrasts (subject, task, repetition) of 
co registered images identified significant treatment effects. 
RESULTS: The difference between PET with VNS and without revealed that left VNS activated right 
thalamus (P<0.0006), right posterior temporal cortex (P<O.0003), left putamen (p<O.0002), and left inferior 
cerebellum (P<0.0009). 
CONCLUSIONS: VNS causes activation of several central areas including contralateral thalamus. 
Localization to the thalamus suggests a possible mechanism to explain the therapeutic benefit, consistent 
with the role of the thalamus as a generator and modulator of cerebral activity. (Neurosurgery 39:426--431, 
1996) 
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V vagus Nerve Stimulation (VNS) is a new and potentially efficacious neurosurgical treatment for medically intractable epilepsy (5, 21). Although 
epilepsy surgery is being performed more frequently, many 
patients are not good candidates and VNS may be another 
neurosurgical treatment option. The results of a large 
randomized study of high versus low intensity VNS in 114 
patients found a mean reduction of seizures of 24.5% for 
patients with high intensity VNS and 6.15% for patients 
with low intensity VNS (21). There is an ongoing large 
multicenter double blind trial of VNS as adjunctive 
treatment for refractory partial epilpepsy. VNS reduces the 
duration of seizures induced by penicillin G and 
pentylentetrazole, and shortens or prevents seizures 
induced by maximum electroshock (10, 23). 
The structures involved in the mechanism of VNS are 
poorly known. Naritoku recently reported increased 
expression of fos immunoreactivity in the habenula of the 
thalamus and in the locus ceruleus with VNS (11). Positron 
emission tomography (PET) H 2150 cerebral blood flow 
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(CBF) imaging is one tool which allows an understanding 
of which neuro-anatomic structures are recruited by VNS 
in human subjects. Determination of the structures activated 
by VNS may help elucidate the antiepileptic mechanism of 
VNS, possibly by identifying inhibitory pathways 
recruited by VNS. 
PATIENTS AND METHODS 
Patients 
Three patients with medically intractable partial seizures 
were each implanted with left vagus nerve stimulators 
(NeuroCybernetic Prosthesis Model 100, Cyberonics Inc, 
Webster, Texas, USA) (14,20). Two patients in this study 
had previous epilepsy surgery (9 and 2.5 years previous to 
VNS) but continued to have significant number of seizures. 
The patients were maintained on their anticonvulsants for 
the duration of study. Each patient had a three month 
baseline period to determine seizure frequency before VNS 
was started. The duration of VNS prior to H/sO PET 
imaging was six, seven, and two months for patient A, B, C 
respectively. The patients' profiles with baseline seizure 
frequency (a month was defined as a 28 day month) as well 
followup seizure frequency with VNS (cumulative seizure 
frequency) up to twelve months are outlined in Table 1. 
Patient A, a 54 year old male has complex partial seizures 
that began at age 33. The complex partial seizures included 
motor automatisms, staring, confusion and laughing 
consistent with gelastic epilepsy. He underwent subdural 
electrode seizure monitoring and had his seizures localized 
to the left frontal lobe. He underwent left frontal resection 
of the anterior and lateral polar segments nine years 
previously at another institution. Despite surgery he still 
had persistent seizures with 10.31 seizures/day during the 
baseline period. The seizure frequency with VNS at twelve 
months was 3.13 seizures/day. With VNS the character of 
the seizures were less intense. 
Patient B, a 44 year old male, has the syndrome of 
hemiatrophy, hemiparesis and intractable epilepsy. The 
seizures were Simple and complex partial seizures of left 
frontal onset. The baseline seizure frequency was 0.36 
seizures /day and at nine months was 0.38 seizures/day. 
However, the patient reported a reduction in intensity and 
duration of seizures. 
TABLE 1. Patient Profile of Seizure Frequency 
Seizures! month 
Baseline with VNS %chang!;;l 
Patient 
A 288.6 87.6 at 12 months -69.6% 
B 10.0 10.5 at 9 months +6.2% 
C 12.0 15.7 at 6 months +30.8% 
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Patient C, a 25 year old male, has bitemporal epilepsy 
(complex partial seizures) with seizure onsets confirmed by 
epilepsy video-telemetry. This patient had a right temporal 
lobectomy with a 70-80% reduction in seizure frequency. 
but still had frequent complex partial seizures 
postoperatively. The patient underwent epilepsy video-
telemetry agian which showed that the seziures that 
persisted arose from the left temporal lobe. Since the 
patient had bitemporal lobe epilepsy the patient could not 
have surgery on both sides and VNS was offered. VNS 
was implanted 2.5 years after the temporal lobectomy. 
Despite a reported reduction in intensity of his seizures, his 
seizure frequency did not change after VNS (Table 1). His 
baseline seizure frequency was 0.43 seizures/day and at 
six months with VNS was 0.56 seizures / day. 
Imaging 
Informed consent for the PET studies was obtained in 
accordance with the U.s.c. Institutional Review Board. In 
all patients, the routine therapeutic VNS was held for one 
hour prior to imaging. Twelve PET scans per patient were 
acquired every 10 minutes. For each scan, a bolus of 35 mCi 
of Hz150 was injected intravenously and a 90 second image 
was acquired. Six scans were performed without VNS 
(off), alternating with 6 scans with VNS (on). VNS with 
standard clinically used settings (2 milliamps at 30 hertz) 
was activated for 60 seconds concurrent with the injection 
of the isotope and scanning. The above intervals were 
chosen because the duration of the anti-epileptic effect of 
VNS in an animal model after constant stimulation for 60 
minutes is maximal at about 3 minutes and is gone by 10 
minutes (18). 
Scans were obtained with the Siemens 953/ A scanner 
(Siemens, Germany) and were reconstructed using 
calculated attenuation correction to an image resolution of 
8 mnfull width at half maximum. Arterial blood samples 
were not obtained, instead images of radioactive counts 
were used to estimate relative cerebral blood flow (3, 9). 
Patients were scanned with eyes and ears unocduded in a 
quiet, semi-darkened room. The patients were continuously 
observed throughout the imaging session and no clinical 
seizures occurred. 
Image Analysis 
Images from each subject were aligned using a within 
subject coregistration method (24). Scans from each subject 
were then transformed to the Talairach coordinate space 
for group statistical comparisons (19, 25). Images were 
then smoothed with a Gaussian filter to a final image 
resolution of 15 mm full width at half maximum. All images 
were globally normalized by proportional rescaling. A 3-
way analysis of variance (ANOV A) where the 3 effects 
were subject (n=3), repetition (n=6) and task (n:::2) was used 
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to identify significant task effects (12). At-statistic, 
calculated on a pixel by pixel basis identified significant 
task effects. Only pixels reaching a threshold of p<0.005 
were included. Pixels where CBF increased significantly 
with VNS were superimposed on a mean CBF image and 
sites of maximal significance were localized in Talairach 
coordinates. 
RESULTS 
VNS caused increased regional cerebral blood flow in all 
three patients with epilepsy. The regions with the most 
significant increase in blood flow were in the left posterior 
cerebellum right middle temporal gyrus, right thalamus, 
and left putamen. Table 2 shows the localization of blood 
flow increases related to left vagal nerve stimulation for 
the three patients. Patient A, who had the best clinical 
response with a 69.6% seizure reduction at twelve months 
had the largest percentage increase of CBF in the left 
posterior cerebellum and right thalamus of 12.6% and 
12.2%. Patient's Band C, who had the least clinical 
response in seizure frequency had the least amount of 
changes in CBF by PET. 
Figure 1 demonstrates the combined image of all three 
patients, where the baseline (VNS off) H}50 PET was 
subtracted from activated (VNS on) H2150 PET. Significant 
increase in CBF were identified in the contralateral 
structures (thalamus and posterior temporal neocortex) as 
well as ipsilateral (inferior cerebellum and putamen). 
Areas from which brain is missing due to previous surgery 
shows as black. 
DISCUSSION 
The primary finding of this pilot study was that VNS, 
using standard clinical settings, caused a measurable and 
significant change in CBF. The most robust changes of 
increased CBF were in the ipsilateral cerebellum and 
contralateral thalamus. Garnett et al also were able to 
demonstrate that VNS causes change in cerebral blood flow 
with H/50 PET (4). They found that VNS in humans causes 
activation of ipsilateral thalamus and cingulate gyrus 
which is in contrast to our finding of contralateral 
FIGURE 1. PET scan of all three patients displayed 
transversely (the right image is through cerebellum, the left 
image is through the level of the temporal lobe). The areas 
of activation are highlighted by arrows. 
thalamus activation. One explanation for the difference is 
that two of their five subjects had electrical seizure activity 
during the study. Brain activity and blood flow in the 
interictal and ictal states are vastly different (8). This 
study used a total of twelve scans per patient as opposed to 
six used by Garnett's group which may have improved the 
signal to noise ratio. Nevertheless, Garnett's and our study 
shows VNS has measurable effect on H/50 CBF. 
The areas with increased CBF are consistent with the 
known anatomy of the vagus nerve. The vagus nerve 
carries general somatic afferents (GSA), general visceral 
afferents (GV A) and efferents. The majority of fibers are 
GV A (15). Most of the afferent fibers first project to the 
nucleus of the solitary tract (NST) but there are 
connections with the medial reticular formation of the 
medulla as well. Left VNS in cat with implanted cerebral 
micro-electrodes recorded increased cellular firing in the 
contralateral ventro-postero-medial nuclei of the thalamus 
(16). Ascending visceral afferent information from vagal 
stimulation in rats is relayed through the parabrachial 
TABLE 2. Localization of Blood Flow Increases to Left Vagal Nerve Stimulation 
rCBF (ml/min/l00 gm) % Increase of rCBF per 
individual 
Brain Region VNSoff VNSon t P A B C 
Left Posterior Cerbellum 69.0 ± 4.3 72.6 ± 1.9 4.52 0.0009 12.6 3.3 0.4 
Right Middle Temporal Gyrus 64.5 ± 5.6 67.2 ± 4.5 4.17 0.0003 7.6 1.0 4.6 
Right Thalamus 59.4 ± 3.2 63.0 ± 3.8 3.83 0.0006 12.2 2.3 4.3 
Left Putamen 64.7 + 12.4 67.7 + 13.3 4.43 0.0002 5.6 3.2 4.4 






j nucleus to the contralateral ventral basal thalamus 
(15).Studies in monkeys with autoradiographic 
anterograde fiber-tracing and horseradish peroxidase 
retrograde cell labeling of the nucleus of the solitary tract 
found projections to the contralateral ventral posterior 
lateral nucleus of the thalamus, and ipsilateral 
parvicelluar part of the ventral posteriomedial thalamic 
nucleus via the central tegmental tract (1). There maybe 
bilateral thalamic projections from one vagus nerve, 
although there appears to be more evidence for the 
contralateral projection. This study supports the studies 
demonstrating contralateral thalamic projection of the 
vagus nerve. 
The cerebellar activation by VNS found in this study is 
also supported by animal data. Electrical stimulation in 
rabbits of the vagus nerve produces field potential in the 
ipsilateral and contralateral nodulus and uvula of the 
cerebellar vermis (13). The responses from the ipsilateral 
vagus nerve were mediated by a mossy fiber pathway, and 
those from the contralateral vagus nerve by a climbing fiber 
pathway. The cerebellar activation by VNS may represent 
direct projections from the vagus nerve. 
The putamen and middle temporal gyrus were also 
activated by VNS but the significance of these areas is less 
well known. There is a paucity of known anatomical 
connections between the vagus nerve and these structures. 
The putamen and temporal gyrus activation may represent 
projections from the thalamus. 
Activation of thalamus and cerebellum may not only 
reflect the anatomy of the vagus nerve, but also the 
mechanism of action. Both the thalamus and cerebellum 
have been implicated in modulating seizures ( 7). Anterior 
thalamic stimulation in humans may have an antiepileptic 
effect (17). The centro-median nuclei of the thalamus on 
both sides were implanted with electrodes and stimulation 
produced significant reduction in seizures (2, 22). 
Cerebellar stimulation in humans with epilepsy has 
deomonstrated some efficacy in reducing seizures (7). The 
sample size for direct cererbellar and thalamic stimulation, 
which is more invasive than VNS, were small. and the 
benefit is still controversial. VNS may provide an indirect 
methcx:l for stimulating these same structures for it's 
possible anti-epileptic effect. 
These pilot data raise a number of interesting questions. 
It will be valuable to determine if there is a correlation 
between the magnitude of blood flow increases in thalamus 
or cerebellum and the effectiveness of VNS in reducing 
'seizures? Does varying the intensity of stimulation recruit 
different structures? Since the vagus nerve stimulator is 
implanted on the left vagus nerve and appears to activate 
the right thalamus, is the VNS more effective in reducing 
seizures that arise from the right hemisphere than the left? 
Is there a different response to VNS between patients with 
temporal lobe epilepsy compared with frontal lobe 
epilepsy? We believe further study of VNS in a larger 
series with H/sO PET in order to confirm these findings 
and answer these questions is warranted. 
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COMMENTS 
Vagus nerve stimulation (VNS) as a treatment for epilep-
sy seems to be effective in some patients, although the 
mechanism of action is unknown and there are no clear 
indications for this alternative treatment. If the data report-
ed in this article can be reproduced in a larger population of 
patients, they may provide insights into the anatomic sub-
strates of any stimulation-induced antiepileptic effects, and 
metabolic patterns might predict which patients are likely 
to benefit from VNS. Although an understanding of the 
central connections of the vagus nerve are clearly important 
in understanding patterns of activation produced by inter-
mittent stimulation, the ultimate effects may involve more 
than expected. Because vagal efferents are stimulated 
antidromicalIy, this will produce action potentials in the 
efferent collaterals, with a much wider distribution of 
synaptic activation than is generally considered. It is, there-
fore, surprising that the areas of increased metabolism in 
this study are so few and so discrete. 
Jerome Engel, Jr. 
Los Angeles, California 
Although it has been known for many years that there 
are patients who can abort their seizures by sensory stimu-
lation, the mechanism of this phenomenon is unknown. 
VNS may also reduce seizure frequency by either sensory or 
motor stimulation. The initial theoretical mechanisms pro-
posed that the nucleus of the solitary tract and brain stem 
reticular centers were stimulated and hence would have a 
diffuse effect resulting in electroencephalographic desyn-
chronization (1). These activation positron emission tomo-
graphic studies by Ko et al., as well as those by Garnett et 
a1. (2) do not show diffuse brain stem increases in cerebral 
blood flow (CBF). The two studies are very dissimilar in 
their positive findings, with Garnett et al. (2) reporting ipsi-
lateral thalamic and anterior cingulate cerebral blood flow 
increases during VNS, and Ko et al. demonstrating con-
tralateral thalamic and posterior temporal cortical increases 
and ipsilateral putamen and cerebellar increases in CBF. 
There are many possible explanations for these differences 
because of study designs, patient selection, etc., but the dif-
ferences in activated CBF patterns raise a concern that these 
patterns may vary with the stimulation parameters, with 
the individuals, or for unknown reasons. 
Garnett et al. (2) studied five patients who were not well 
characterized beyond that they experienced medically 
intractable seizures. VNS stimulation parameters were not 
indicated. Two of the five patients had electrical evidence 
of seizure activity during the positron emission tomography 
scan. Ko et al. provide a far better characterization of their 
patients; however, only one of these patients has demon-
strated a decreased frequency of seizures in response to 
VNS. Two of these patients underwent prior cerebral resec-
tions of frontal or temporal lobes, and the third patient has 
hemiatrophy, suggesting that all of these patients have 
abnormal brains. Areas of resection clearly cannot be acti-
vated by VNS, and it is poSSible that such resections might 
alter regional CBF activations at other sites. Furthermore, 
although no clinical seizures were observed, subclinical 
seizures could easily have been overlooked because elec-
troencephalographic monitoring was not performed. 
The duration of stimulation used in Ko's study was twice 
as long as that for therapeutic VNS, and patients receiving 
therapeutic VNS have individualized current levels that are 
not often as high as 2 mAo It is therefore possible that CBF 
patterns activated by VNS may vary with stimulation para-
meters. Because the investigators chose parameters that 
differed from therapeutic VNS, their findings may be more 
relevant to central projections of vagal nuclei but not neces-
sarily indicative of which structures mediate the therapeutic 
effects of VNS. 
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Finally, both studies have used too few patients to identi-
fy the very small nuclei in the brain stem that could have 
been activated by VNS. Clearly, the nucleus of the solitary 
tract or the motor nucleus of X should have been activated. 
There is enough ambiguity in both of these studies to ques-
tion whether a diffuse or a specific pathway is the mecha-
nism for the decrease in seizure activity. Although I can 
accept a potential thalamic mechanism, the statement by the 
authors that cerebellar stimulation "showed some efficacy 
in reducing seizures" has not held up to more rigorous qoU-
ble-blind studies (3, 4). I would, however, agree with the 
authors that the most important finding is that there are 
indeed significant changes in CBF with VNS. It remains for 
future studies to determine exactly how, when, and why the 
activated CBF patterns change and what significance these 
may have for the control of seizure activity. 
Roy A.E. Bakay 
Atlanta, Georgia 
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The role of VNS for the treatment of epilepsy remains 
unclear, in part because it has an inconsistent effect. When it 
does have an effect, it most commonly is mild. Perhaps 
some of this is because the patients who respond best to this 
treatment are not yet clearly identified. As a consequence, 
better understanding of the mechanism of action would be 
helpful, just as a clearer understanding of the mechanism 
actions of certain drugs improves their application to cer-
tain forms of epilepsy. For this reason, work as described in 
this article can be extremely useful in understanding puta-
tive effects of VNS. 
It has been known for years that many of the epilepsias 
have a higher probability of interictal electroencephalo-
graphic spikes and seizures during periods of non-REM 
sleep and/or inattention. Put another way, some patients 
commonly have fewer seizures during periods of increased 
alertness when the electroencephalography shows relative 
desynchronization. From animal studies (I), it has been 
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shown that focused attention causes increased interneu-
ronal desynchronization and, on the single neuron level, a 
decrease in epileptic birth firing patterns. Intracellular sin-
gle neuronal studies show that pyramidal tract cells hyper-
polarize during reticular stimulation. Given these findings, 
and given the present findings that VNS increases blood 
flow to the reticular formation and thalamus, it is not diffi-
cult to understand a mild anticonvulsant effect for some 
patients with epilepsy solely on the above basis. The prob-
lem is extrapolating experimental data to the situation in 
humans and extrapolating blood flow changes in neuronal 
behavior. Nonetheless, studies of this nature will help to 
clarify the effects of VNS on epilepsy. 
Allen R. Wyler 
Seattle, Washington 
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This article by Ko et al., evaluates three patients with 
medically intractable epilepsy who had left vagal nerve 
stimulators placed and positron emission tomographic 
scans obtained with and without VNS. All three of the 
patients studied had structural abnormalities of the brain. 
One had undergone left frontal resection, one had David-
Offdyke-Mason syndrome, and the third had undergone 
right temporal lobectomy. The first of these three patients 
experienced improvement in his seizure frequency with 
VNS. The other two did not. Using positron emission 
tomography, the authors found that the left vagal nerve 
stimulation activated the right thalamus, right posterior 
temporal cortex, left putamen, and left inferior cerebellum. 
These findings differ from previous reports. 
The literature and most people's experience with VNS 
demonstrate that it can decrease seizure frequency in some 
patients but rarely cure patients. Therefore, it has not been 
used as an alternative to medication or surgery, but rather 
has been used in patients who have been proven medically 
intractable and are either not candidates for surgery or have 
failed resective surgery. There are a number of theorectical 
reasons why VNS can help to decrease seizure frequency in 
selected patients; however, none of these are evaluated in 
this article. It will be important to evaluate more patients 
with vagal nerve stimulators so that confounding factors, 
such as structural abnormalities of the brain, whether the 
stimulator was helpful, the lobe of seizure onset, etc., can be 
more clearly understood. 
Daniel L. Silbergeld 
St. Louis, Missouri 
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